Jay Jacoby

1PUBLICATIONS
1CO-AUTHORS
Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 18, 2025
Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies.

Jay Jacoby, Deva Mahalingam, Angela Alistar

Pageof 1

Frequent Collaborators

1 joint publications

Justin Moser